Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study

The purpose of the present study was to determine the postoperative analgesic effects of lornoxicam and the reduction in tramadol consumption. Fourty patients of ASA class I-II, 18-70 years of age, undergoing thyroidectomy were assigned in a randomized manner into two groups: GroupL received 8 mg of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Aǧrı 2006-04, Vol.18 (2), p.27-33
Hauptverfasser: Arslan, Mustafa, Tuncer, Bilge, Babacan, Avni, Taneri, Ferit, Karadenizli, Yener, Onuk, Erhan, Ege, Bahadir
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 33
container_issue 2
container_start_page 27
container_title Aǧrı
container_volume 18
creator Arslan, Mustafa
Tuncer, Bilge
Babacan, Avni
Taneri, Ferit
Karadenizli, Yener
Onuk, Erhan
Ege, Bahadir
description The purpose of the present study was to determine the postoperative analgesic effects of lornoxicam and the reduction in tramadol consumption. Fourty patients of ASA class I-II, 18-70 years of age, undergoing thyroidectomy were assigned in a randomized manner into two groups: GroupL received 8 mg of lornoxicam i.v. at the end of the operation followed by 8 mg of lornoxicam b.i.d., i.v. for 24 hours postoperatively. GroupP received 4 ml of saline solution i.v. at the end of the operation and the same amount b.i.d., i.v. for 24 hours postoperatively. The requirements for supplemental analgesics were recorded at 0-6, 6-12 and 12-24 hour intervals. Postoperative pain scores were evaluated at 15th min. and 1, 2, 4, 6, 8, 12, 18 and 24th hours using Visual Analogue Scale (VAS). The time to first analgesic requirement was significantly longer in GroupL compared to GroupP (101.7 vs 37.9 min, p
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68121138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68121138</sourcerecordid><originalsourceid>FETCH-LOGICAL-g234t-d120f1bf76f2b3d26ad27a2ec1a807c54c1c60635a1c6221c2fdc0cda87c855a3</originalsourceid><addsrcrecordid>eNo1kEtLxDAUhbtQnGGcvyBZuSvk0ZfuZPAFA7rQdbm9uZmJpE1NUrH-eguOZ_MdOIezOGfZWijOc86FXGXbGD_4orKoGlFdZCtR8-ZGKrXOjq8-Jj9SgGS_iMEA7kDRIiNjCFNk3jDnw-C_LULPwCQKLB3n4K1ect_PtwzY6ACp8wz9kIJ3jjQLMGjf25_FxjTp-TI7N-AibU_cZO8P92-7p3z_8vi8u9vnB6mKlGshuRGdqSsjO6VlBVrWIAkFNLzGskCBFa9UCQulFCiNRo4amhqbsgS1ya7_dsfgPyeKqe1tRHIOBvJTbJcHpBCqWYpXp-LU9aTbMdgewtz-f6N-Ae91Yp8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68121138</pqid></control><display><type>article</type><title>Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Arslan, Mustafa ; Tuncer, Bilge ; Babacan, Avni ; Taneri, Ferit ; Karadenizli, Yener ; Onuk, Erhan ; Ege, Bahadir</creator><creatorcontrib>Arslan, Mustafa ; Tuncer, Bilge ; Babacan, Avni ; Taneri, Ferit ; Karadenizli, Yener ; Onuk, Erhan ; Ege, Bahadir</creatorcontrib><description>The purpose of the present study was to determine the postoperative analgesic effects of lornoxicam and the reduction in tramadol consumption. Fourty patients of ASA class I-II, 18-70 years of age, undergoing thyroidectomy were assigned in a randomized manner into two groups: GroupL received 8 mg of lornoxicam i.v. at the end of the operation followed by 8 mg of lornoxicam b.i.d., i.v. for 24 hours postoperatively. GroupP received 4 ml of saline solution i.v. at the end of the operation and the same amount b.i.d., i.v. for 24 hours postoperatively. The requirements for supplemental analgesics were recorded at 0-6, 6-12 and 12-24 hour intervals. Postoperative pain scores were evaluated at 15th min. and 1, 2, 4, 6, 8, 12, 18 and 24th hours using Visual Analogue Scale (VAS). The time to first analgesic requirement was significantly longer in GroupL compared to GroupP (101.7 vs 37.9 min, p&lt;0.001). Pain scores were significantly lower in GroupL compared to GroupP at 15th min, 1, 8 ,12 and 18th hours. Twenty four hour analgesic consumption was significantly lower in GroupL compared to GroupP (p&lt;0.05). The amount of tramadol consumed in GroupL was 60% lower compared to GroupP (100 mg and 250 mg (mean), respectively). 100% of the patients in GroupL and 60 % of the patients in GroupP needed supplemental analgesics. The degree of satisfaction with postoperative pain management was excellent in 95 % of patients in GroupL and 25 % of patients in GroupP. Eighteen patients in GroupP and 9 patients in GroupL had nausea (p=0.002), and fifteen patients in GroupP and 8 patients in GroupL had vomiting (p=0.025). Lornoxicam decreased the opioid need, the incidence of nausea and vomiting and postoperative pain scores. Moreover, it was observed that the time needed for the first analgesic requirement was prolonged following thyroidectomies.</description><identifier>ISSN: 1300-0012</identifier><identifier>PMID: 17089233</identifier><language>eng</language><publisher>Turkey</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Female ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Pain Measurement ; Pain, Postoperative - prevention &amp; control ; Piroxicam - administration &amp; dosage ; Piroxicam - analogs &amp; derivatives ; Piroxicam - therapeutic use ; Thyroidectomy ; Treatment Outcome</subject><ispartof>Aǧrı, 2006-04, Vol.18 (2), p.27-33</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17089233$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arslan, Mustafa</creatorcontrib><creatorcontrib>Tuncer, Bilge</creatorcontrib><creatorcontrib>Babacan, Avni</creatorcontrib><creatorcontrib>Taneri, Ferit</creatorcontrib><creatorcontrib>Karadenizli, Yener</creatorcontrib><creatorcontrib>Onuk, Erhan</creatorcontrib><creatorcontrib>Ege, Bahadir</creatorcontrib><title>Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study</title><title>Aǧrı</title><addtitle>Agri</addtitle><description>The purpose of the present study was to determine the postoperative analgesic effects of lornoxicam and the reduction in tramadol consumption. Fourty patients of ASA class I-II, 18-70 years of age, undergoing thyroidectomy were assigned in a randomized manner into two groups: GroupL received 8 mg of lornoxicam i.v. at the end of the operation followed by 8 mg of lornoxicam b.i.d., i.v. for 24 hours postoperatively. GroupP received 4 ml of saline solution i.v. at the end of the operation and the same amount b.i.d., i.v. for 24 hours postoperatively. The requirements for supplemental analgesics were recorded at 0-6, 6-12 and 12-24 hour intervals. Postoperative pain scores were evaluated at 15th min. and 1, 2, 4, 6, 8, 12, 18 and 24th hours using Visual Analogue Scale (VAS). The time to first analgesic requirement was significantly longer in GroupL compared to GroupP (101.7 vs 37.9 min, p&lt;0.001). Pain scores were significantly lower in GroupL compared to GroupP at 15th min, 1, 8 ,12 and 18th hours. Twenty four hour analgesic consumption was significantly lower in GroupL compared to GroupP (p&lt;0.05). The amount of tramadol consumed in GroupL was 60% lower compared to GroupP (100 mg and 250 mg (mean), respectively). 100% of the patients in GroupL and 60 % of the patients in GroupP needed supplemental analgesics. The degree of satisfaction with postoperative pain management was excellent in 95 % of patients in GroupL and 25 % of patients in GroupP. Eighteen patients in GroupP and 9 patients in GroupL had nausea (p=0.002), and fifteen patients in GroupP and 8 patients in GroupL had vomiting (p=0.025). Lornoxicam decreased the opioid need, the incidence of nausea and vomiting and postoperative pain scores. Moreover, it was observed that the time needed for the first analgesic requirement was prolonged following thyroidectomies.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pain Measurement</subject><subject>Pain, Postoperative - prevention &amp; control</subject><subject>Piroxicam - administration &amp; dosage</subject><subject>Piroxicam - analogs &amp; derivatives</subject><subject>Piroxicam - therapeutic use</subject><subject>Thyroidectomy</subject><subject>Treatment Outcome</subject><issn>1300-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtLxDAUhbtQnGGcvyBZuSvk0ZfuZPAFA7rQdbm9uZmJpE1NUrH-eguOZ_MdOIezOGfZWijOc86FXGXbGD_4orKoGlFdZCtR8-ZGKrXOjq8-Jj9SgGS_iMEA7kDRIiNjCFNk3jDnw-C_LULPwCQKLB3n4K1ect_PtwzY6ACp8wz9kIJ3jjQLMGjf25_FxjTp-TI7N-AibU_cZO8P92-7p3z_8vi8u9vnB6mKlGshuRGdqSsjO6VlBVrWIAkFNLzGskCBFa9UCQulFCiNRo4amhqbsgS1ya7_dsfgPyeKqe1tRHIOBvJTbJcHpBCqWYpXp-LU9aTbMdgewtz-f6N-Ae91Yp8</recordid><startdate>200604</startdate><enddate>200604</enddate><creator>Arslan, Mustafa</creator><creator>Tuncer, Bilge</creator><creator>Babacan, Avni</creator><creator>Taneri, Ferit</creator><creator>Karadenizli, Yener</creator><creator>Onuk, Erhan</creator><creator>Ege, Bahadir</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200604</creationdate><title>Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study</title><author>Arslan, Mustafa ; Tuncer, Bilge ; Babacan, Avni ; Taneri, Ferit ; Karadenizli, Yener ; Onuk, Erhan ; Ege, Bahadir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g234t-d120f1bf76f2b3d26ad27a2ec1a807c54c1c60635a1c6221c2fdc0cda87c855a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pain Measurement</topic><topic>Pain, Postoperative - prevention &amp; control</topic><topic>Piroxicam - administration &amp; dosage</topic><topic>Piroxicam - analogs &amp; derivatives</topic><topic>Piroxicam - therapeutic use</topic><topic>Thyroidectomy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arslan, Mustafa</creatorcontrib><creatorcontrib>Tuncer, Bilge</creatorcontrib><creatorcontrib>Babacan, Avni</creatorcontrib><creatorcontrib>Taneri, Ferit</creatorcontrib><creatorcontrib>Karadenizli, Yener</creatorcontrib><creatorcontrib>Onuk, Erhan</creatorcontrib><creatorcontrib>Ege, Bahadir</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Aǧrı</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arslan, Mustafa</au><au>Tuncer, Bilge</au><au>Babacan, Avni</au><au>Taneri, Ferit</au><au>Karadenizli, Yener</au><au>Onuk, Erhan</au><au>Ege, Bahadir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study</atitle><jtitle>Aǧrı</jtitle><addtitle>Agri</addtitle><date>2006-04</date><risdate>2006</risdate><volume>18</volume><issue>2</issue><spage>27</spage><epage>33</epage><pages>27-33</pages><issn>1300-0012</issn><abstract>The purpose of the present study was to determine the postoperative analgesic effects of lornoxicam and the reduction in tramadol consumption. Fourty patients of ASA class I-II, 18-70 years of age, undergoing thyroidectomy were assigned in a randomized manner into two groups: GroupL received 8 mg of lornoxicam i.v. at the end of the operation followed by 8 mg of lornoxicam b.i.d., i.v. for 24 hours postoperatively. GroupP received 4 ml of saline solution i.v. at the end of the operation and the same amount b.i.d., i.v. for 24 hours postoperatively. The requirements for supplemental analgesics were recorded at 0-6, 6-12 and 12-24 hour intervals. Postoperative pain scores were evaluated at 15th min. and 1, 2, 4, 6, 8, 12, 18 and 24th hours using Visual Analogue Scale (VAS). The time to first analgesic requirement was significantly longer in GroupL compared to GroupP (101.7 vs 37.9 min, p&lt;0.001). Pain scores were significantly lower in GroupL compared to GroupP at 15th min, 1, 8 ,12 and 18th hours. Twenty four hour analgesic consumption was significantly lower in GroupL compared to GroupP (p&lt;0.05). The amount of tramadol consumed in GroupL was 60% lower compared to GroupP (100 mg and 250 mg (mean), respectively). 100% of the patients in GroupL and 60 % of the patients in GroupP needed supplemental analgesics. The degree of satisfaction with postoperative pain management was excellent in 95 % of patients in GroupL and 25 % of patients in GroupP. Eighteen patients in GroupP and 9 patients in GroupL had nausea (p=0.002), and fifteen patients in GroupP and 8 patients in GroupL had vomiting (p=0.025). Lornoxicam decreased the opioid need, the incidence of nausea and vomiting and postoperative pain scores. Moreover, it was observed that the time needed for the first analgesic requirement was prolonged following thyroidectomies.</abstract><cop>Turkey</cop><pmid>17089233</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1300-0012
ispartof Aǧrı, 2006-04, Vol.18 (2), p.27-33
issn 1300-0012
language eng
recordid cdi_proquest_miscellaneous_68121138
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Pain Measurement
Pain, Postoperative - prevention & control
Piroxicam - administration & dosage
Piroxicam - analogs & derivatives
Piroxicam - therapeutic use
Thyroidectomy
Treatment Outcome
title Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T20%3A57%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postoperative%20analgesic%20effects%20of%20lornoxicam%20after%20thyroidectomy:%20a%20placebo%20controlled%20randomized%20study&rft.jtitle=A%C7%A7r%C4%B1&rft.au=Arslan,%20Mustafa&rft.date=2006-04&rft.volume=18&rft.issue=2&rft.spage=27&rft.epage=33&rft.pages=27-33&rft.issn=1300-0012&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E68121138%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68121138&rft_id=info:pmid/17089233&rfr_iscdi=true